Package 0574-0228-01

{"route": ["ORAL"], "spl_id": "55072852-c532-448e-935e-102e981cf698", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776"], "upc": ["0305740229019", "0305740228012", "0305740227015"], "unii": ["0J48LPH2TH", "N1SN99T69T"], "rxcui": ["898362", "898367", "898372"], "spl_set_id": ["3e2d3974-38b0-49d0-8020-f74107584724"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "manufacturer_name": ["Padagis US LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (0574-0228-01)", "package_ndc": "0574-0228-01", "marketing_end_date": "20270331", "marketing_start_date": "20190407"}], "brand_name": "benazepril hydrochloride and hydrochlorothiazide", "product_id": "0574-0228_55072852-c532-448e-935e-102e981cf698", "dosage_form": "TABLET", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Decreased Blood Pressure [PE]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "0574-0228", "generic_name": "benazepril hydrochloride and hydrochlorothiazide", "labeler_name": "Padagis US LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "benazepril hydrochloride and hydrochlorothiazide", "active_ingredients": [{"name": "BENAZEPRIL HYDROCHLORIDE", "strength": "20 mg/1"}, {"name": "HYDROCHLOROTHIAZIDE", "strength": "25 mg/1"}], "application_number": "NDA020033", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_end_date": "20270331", "marketing_start_date": "20190407"}